Skip to content

Clinical trials

Phase 2 Central Nervous System Neoplasms trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Central Nervous System Neoplasms Phase: Phase 2 Country / region: United States Clear all

170 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200014
200110
200211
200310
20046
200510
200610
20078
20082
20095
20101
20113
20121
20131
20151
201710
20182
20191
20201
20212
20223
20241
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed128
Terminated15
Active, not recruiting8
Unknown status8
Recruiting6
Withdrawn4
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)18
Duke University13
Children's Oncology Group11
Memorial Sloan Kettering Cancer Center11
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins10
Dana-Farber Cancer Institute7
Radiation Therapy Oncology Group7
Alliance for Clinical Trials in Oncology5
Northwestern University5
St. Jude Children's Research Hospital5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Central Nervous System Neoplasms170
Glioblastoma76
Brain Neoplasms75
Gliosarcoma68
Astrocytoma63
Glioma48
Oligodendroglioma42
Medulloblastoma27
Ependymoma22
Neuroblastoma21

Trials

Showing 1 to 25 of 170. Each trial links to its page on Pharma Observatory.

70 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.